Sector News

As India’s EV market moves beyond early adopters and into the mainstream, Tata Motors Passenger Vehicles intends to launch four new electric vehicle models and over ten refreshes of its current lineup by FY31 and targets achieving over 30% EV penetration. Read ahead to know more.

The Department of Telecommunications has notified rules under the Telecommunications Act, 2023, to replace India’s decades-old license-based telecom regime with an authorisation-based regime. Operators including Jio, Airtel and Vodafone Idea will transition to the new system through a phased process. Read ahead to know more.

India is working towards a target of $100 billion in textile exports by 2030. Policymakers and industry leaders highlighted sustainability, free trade agreements and stronger export competitiveness.

Amazon will invest an additional $13 billion in AI and cloud infrastructure in India by 2030. It will take its total planned investment above $21 billion and expand AWS capacity, logistics operations and digital initiatives.

Mutual funds cut IT sector holdings by ₹4,810 crore in May even as overall equity exposure rose ₹61,404 crore, rotating toward healthcare and industrials amid Accenture's guidance cut and global spending concerns.

The Department of Telecommunications has retained the existing pricing structure for backhaul spectrum in its draft rules, rejecting a proposal from TRAI to cut charges by up to 55%. The decision keeps costs elevated for telecom operators at a time of heavy network investment. Read ahead to know more.

The Nifty IT index fell 2.01% to 27,072.40 as of 12:30 PM on Tuesday, emerging as one of the worst-performing sectoral indices. Selling was broad-based across technology stocks, with Infosys, TCS, Wipro, LTIMindtree and HCLTech among the major losers. The decline comes amid continued weakness in global technology shares and follows a sharp correction in the sector over the past week.

The USFDA has approached Indian drugmakers through IDMA to help address a shortage of cancer drug ifosfamide in the US. This can create potential supply opportunities for India's pharmaceutical industry.

NARCL plans acquisitions beyond its sovereign guarantee model, targeting smaller stressed assets as recoveries improve. The bad bank has acquired ₹1.66 lakh crore of debt so far. Read more.